Tradestie Institutional Equity Comparison Engine

GRAL vs ADPT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ADPT Overall Edge

ADPT Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Adaptive Biotechnologies Corporation Common Stock (ADPT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while GRAL counters with relative strength in Valuation. Fundamentally, GRAL trades at 1.1x Forward P/E with -332.0% operating margin (+3.7% YoY revenue) versus ADPT at N/M Forward P/E and -16.2% operating margin (-10.7% YoY). In options structure, GRAL sits in BREAKDOWN (53rd %ile IV; Dealer Gamma Walls on Pro) against ADPT sits in CONSOLIDATION (36th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner GRAL
GRAL 1.1x vs ADPT N/M Fwd P/E
Growth & Margin Winner ADPT
Op Margin -332.0% vs -16.2% ยท YoY +3.7% vs -10.7%
Momentum & Technical Winner ADPT
1Y +24.6% vs +97.1% ยท 52W Pos 51% vs 78%
Options & Structure Winner ADPT
BREAKDOWN (53rd %ile IV) vs CONSOLIDATION (36th %ile IV)
GRAL NASDAQ
GRAIL, Inc. Common Stock
Services-Medical Laboratories
$105.60
-8.88% 1D
Market Cap $5.2B
1M Return -10.36%
1Y Return +24.57%
Forward P/E 1.1x
Unified AI Score
54.5 / 100 HOLD
Tech 35.0 Fund 49.0 Flow 57.0 Mom 60.0
ADPT NASDAQ
Adaptive Biotechnologies Corporation Common Stock
Biological Products, (No Disgnostic Substances)
$27.87
-4.03% 1D
Market Cap $4.7B
1M Return +16.03%
1Y Return +97.1%
Forward P/E N/M
Unified AI Score
43.8 / 100 HOLD
Tech 15.0 Fund 43.0 Flow 69.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GRAL +24.57% ADPT +97.1% Spread: +70.18 pp (ADPT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period GRAL Revenue ADPT Revenue GRAL Op. Margin ADPT Op. Margin Margin Edge
FY2018 N/A $60M N/A -89.4% ADPT
FY2019 N/A $90M N/A -92.1% ADPT
FY2020 N/A $100M N/A -155.3% ADPT
FY2021 N/A $150M N/A -135.4% ADPT
FY2022 N/A $190M N/A -108.0% ADPT
FY2023 $90M $170M -1627.6% -133.3% ADPT
FY2024 $130M $180M -1743.0% -90.8% ADPT
FY2025 $150M $280M -382.0% -20.6% ADPT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GRAL (6) vs ADPT (4)
Institutional Metric GRAL ADPT Criterion Row Winner
Market Capitalization Scale $5.2B $4.7B Larger Scale GRAL
Trailing P/E Ratio Valuation 1.1x N/M Lower Multiple GRAL
Forward P/E Ratio Valuation 1.1x N/M Lower Multiple GRAL
Revenue Growth (YoY) Growth +3.7% -10.7% Higher Growth GRAL
Operating Margin (TTM) Profitability -332.0% -16.2% Higher Margin ADPT
Net Profit Margin Profitability -243.8% -23.7% Higher Margin ADPT
Return on Equity (ROE) Capital Efficiency -17.3% -36.4% Higher ROE GRAL
52-Week Range Position Momentum 51% ($42โ€“$166) 78% ($12โ€“$32) Stronger Trend ADPT
Beta / 30D Volatility Risk Regime 3.09ฮฒ ยท 99% Vol 1.74ฮฒ ยท 60% Vol Lower Realized Risk ADPT
Unified Institutional Score Composite Signal 54.5 / 100 (HOLD) 43.8 / 100 (HOLD) Higher Composite GRAL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GRAL vs ADPT Buy Guide
GRAL BREAKDOWN
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 53rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live GRAL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ADPT CONSOLIDATION
69d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 36th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ADPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GRAL nor ADPT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.